Prevalence ratio of a sick-leave spell >90 days following PCI for <i>all patients</i> and for <i>patients with ≤90 sick-leave days</i> immediately before the intervention.

1<p>Adjusted for age, indication, diabetes, history of cardiovascular disease, socio economic position, and >90 sick-leave days <i>in total</i> the year prior to PCI.</p>*<p>p-value <0.05;</p>**<p>p-value <0.01;</p>***<p>p-value <0.001.</p

Prevalence ratio of a sick-leave spell >90 days following PCI for <i>all patients</i> and for <i>patients with ≤90 sick-leave days</i> immediately before the intervention.

1<p>Adjusted for age and >90 sick-leave days <i>in total</i> during the year before PCI.</p>2<p>Myocardial infarction.</p>3<p>Acute myocardial infarction, heart failure, cerebrovascular disease and transient cerebral ischeamic attacks.</p>4<p>Including non-manual employees at intermediate level.</p>5<p>Not adjusted for >90 sick-leave days <i>in total</i> during the year before PCI.</p>*<p>p-value <0.05;</p>**<p>p-value <0.01;</p>***<p>p-value <0.001.</p

Sick-leave days in the first sick-leave spell following coronary revascularisation.

1<p>Those with no data on sick-leave benefits following the intervention were coded as having had 14 sick-leave days, in order to not underestimate the number of sick-leave days.</p

Patient characteristics.

1<p>Myocardial infarction.</p>2<p>Primarily from the quality registers or hospitalised diabetes mellitus from the Patient register.</p>3<p>Cancer, renal failure and transient cerebral ischaemic attacks.</p>4<p>Percent of those with a socio-economic classification.</p>5<p>Including non-manual employees at intermediate level.</p

First time CABG and PCI in Sweden in 1994–2006.

<p>First time CABG and PCI in Sweden in 1994–2006.</p

Median number of sick-leave days in the sick-leave spell following CABG and PCI in 1994–2006.

<p>Median number of sick-leave days in the sick-leave spell following CABG and PCI in 1994–2006.</p

Prevalence ratio of a sick- leave spell >180 days following CABG for <i>all patients</i> and for <i>patients with ≤90 sick-leave days</i> immediately before the intervention.

1<p>Adjusted for age and >90 sick-leave days <i>in total</i> during the year before CABG.</p>2<p>Myocardial infarction.</p>3<p>Acute myocardial infarction, heart failure, cerebrovascular disease and transient cerebral ischeamic attacks.</p>4<p>Including non-manual employees at intermediate level.</p>5<p>Not adjusted for >90 sick-leave days <i>in total</i> during the year before CABG.</p>*<p>p-value <0.05;</p>**<p>p-value <0.01;</p>***<p>p-value <0.001.</p

Proportion of patients with at least 365 sick-leave days in the sick-leave spell following CABG and PCI in 1994–2006.

<p>Proportion of patients with at least 365 sick-leave days in the sick-leave spell following CABG and PCI in 1994–2006.</p